Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleOriginal Research

Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada

Tricia Tang, Danielle Hessler, William H. Polonsky, Lawrence Fisher, Beverly Reed, Tanya Irani, Urvi Desai and Magaly Perez-Nieves
The Journal of the American Board of Family Medicine March 2020, 33 (2) 198-210; DOI: https://doi.org/10.3122/jabfm.2020.02.190157
Tricia Tang
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Danielle Hessler
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William H. Polonsky
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
PhD, CDE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lawrence Fisher
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beverly Reed
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
MSN, RN, CDE, CNML
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tanya Irani
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Urvi Desai
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magaly Perez-Nieves
From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).
MPH, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Demographics and Clinical Characteristics of Surveyed Adult Type 2 Diabetes Mellitus Patients Experiencing Psychological Insulin Resistance Before Regular Insulin Use, 2017

    CharacteristicValues by Location
    United States (n = 120)Canada (n = 74)
    Type of recruitment, n (%)
     Panel83 (69.2)60 (81.1)
     Health care provider referral0 (0.0)13 (17.6)
     Recruitment through Diabetes.co.uk1 (0.8)1 (1.4)
     TCOYD registry36 (30.0)0 (0.0)
    Age, mean (SD)56.8 (10.9)55.8 (10.2)
    Male, n (%)35 (29.2)47 (63.5)
    Ethnicity, n (%)
     United States
      Asian5 (4.2)—
      Black/African American6 (5.0)—
      Latino/Hispanic/Chicano10 (8.3)—
      Non-Hispanic white/Caucasian89 (74.2)—
      Multiple ethnic background5 (4.2)—
      Other5 (4.2)—
     Canada
      Canadian—59 (79.7)
      English—4 (5.4)
      French—3 (4.1)
      Other—8 (10.8)
    Bachelor’s degree (e.g., BA or BS) or higher education, n (%)45 (37.5)28.0 (37.8)
    Current employment status, n (%)
     Working full-time or part-time52 (43.3)37 (50.0)
     Not employed18 (15.0)10 (13.5)
     Retired33 (27.5)20 (27.0)
     Other17 (14.2)7 (9.5)
    Years since first diabetes diagnosis to basal insulin initiation, mean (SD)9.8 (8.0)8.9 (7.3)
    Year of first basal insulin use, n (%)
     201547 (39.2)26 (35.1)
     201651 (42.5)36 (48.6)
     201715 (12.5)11 (14.9)
    Prior use of injectable diabetes medications, n (%)25 (20.8)15 (20.3)
    HbA1c before starting insulin*
     HbA1c (%), mean (SD)9.5 (1.9)10.0 (2.8)
     Unknown, n (%)40 (33.3)29 (39.2)
    HbA1c at the time of survey*
     HbA1c (%), mean (SD)7.9 (1.5)7.5 (2.0)
     Unknown, n (%)22 (18.3)17 (23.0)
    BMI before starting insulin (kg/m2)
     Mean (SD)35.5 (9.6)30.6 (8.2)
    BMI at the time of the survey (kg/m2)
     Mean (SD)34.6 (8.4)30.2 (7.9)
    • BA, Bachelor of Arts; BS, Bachelor of Science; BMI, body mass index; HbA1c, hemoglobin A1c; SD, standard deviation; TCOYD, Taking Control of Your Diabetes.

    • ↵* Mean HbA1c was calculated among the patients who had a test in the past year and knew the test result.

    • View popup
    Table 2.

    Thoughts and Feelings Right Before Taking Insulin for the First Time—Surveyed Adult Type 2 Diabetes Mellitus Patients Experiencing Psychological Insulin Resistance Before Regular Insulin Use, 2017

    Thoughts and Feelings before Starting Insulin for the First Time, n (%) Agree/Strongly AgreeValues by Location
    United States (n = 120)Canada (n = 74)
    Taking insulin would mean I had failed to manage my diabetes with diet and tablets.102 (85.0)58 (78.4)
    Taking insulin would mean my diabetes had become much worse.103 (85.8)47 (63.5)
    Taking insulin would help to prevent complications of diabetes.80 (66.7)53 (71.6)
    Taking insulin would mean other people would see me as a sick/sicker person.60 (50.0)30 (40.5)
    Taking insulin would make life less flexible.80 (66.7)49 (66.2)
    I was afraid of injecting myself with a needle.74 (61.7)41 (55.4)
    Taking insulin would increase the risk of low blood glucose levels (hypoglycemia).42 (35.0)33 (44.6)
    Taking insulin would help to improve my health.78 (65.0)53 (71.6)
    Insulin would cause weight gain.51 (42.5)29 (39.2)
    Managing insulin injections would take a lot of time and energy.63 (52.5)40 (54.1)
    Taking insulin would mean I would have to give up activities I enjoy.31 (25.8)25 (33.8)
    Taking insulin would mean my health would deteriorate.34 (28.3)24 (32.4)
    Injecting insulin would be embarrassing.45 (37.5)23 (31.1)
    Injecting insulin would be painful.73 (60.8)44 (59.5)
    It would be difficult to inject the right amount of insulin correctly at the right time every day.55 (45.8)39 (52.7)
    Taking insulin would make it more difficult to fulfill my responsibilities (at work, at home).36 (30.0)23 (31.1)
    Taking insulin would help to maintain good control of blood glucose (sugar levels).81 (67.5)54 (73.0)
    Being on insulin would cause family and friends to be more concerned about me.70 (58.3)40 (54.1)
    Taking insulin would help to improve my energy level.32 (26.7)34 (45.9)
    Taking insulin would make me more dependent on my doctor.53 (44.2)36 (48.6)
    Taking insulin might cause serious health problems, like blindness, kidney problems or amputations.26 (21.7)24 (32.4)
    Taking insulin would mean that my diabetes would become a much more serious disease.64 (53.3)40 (54.1)
    Taking insulin would mean that I had failed, that I hadn’t done a good enough job taking care of my diabetes.95 (79.2)51 (68.9)
    Taking insulin would cause me to lose my job.14 (11.7)16 (21.6)
    Taking insulin would mean that I would need to take insulin forever.96 (80.0)54 (73.0)
    ITAS Scores
     Total negative items ITAS*,†,‡, mean (SD)54.2 (9.9)53.1 (11.2)
     Total positive items ITAS*,†,§, mean (SD)14.3 (2.1)15.1 (2.8)
     Total ITAS*,†,‡,§,∥, mean (SD)64.0 (10.5)62.0 (11.4)
    • ITAS, Insulin Treatment Appraisal Scale; SD, standard deviation.

    • ↵* Agreement with statements was categorized as “strongly disagree” (corresponding to 1), “disagree” (corresponding to 2), “neither agree nor disagree” (corresponding to 3), “agree” (corresponding to 4), and “strongly agree” (corresponding to 5).

    • ↵† ITAS scoring is based on Snoek et al.32

    • ↵‡ Total negative ITAS score was calculated by averaging the level of agreement to responses of 16 negatively oriented survey questions.

    • ↵§ Total positive ITAS score was calculated by averaging the level of agreement to responses of four positively oriented survey questions.

    • ↵∥ Total ITAS score was calculated by averaging the level of agreement to responses of the negatively oriented and positively oriented survey questions. The values of the positive-oriented survey questions were reversed (5 = 1, 4 = 2, 3 = 3, 2 = 4, 1 = 5). Higher total ITAS score indicates more negative appraisal of insulin treatment.

    • View popup
    Table 3.

    Patient Reaction When Health care Provider First Said It Was Time to Start Taking Insulin and Insulin Taking Behavior of Surveyed Adult Type 2 Diabetes Mellitus Patients Experiencing Psychological Insulin Resistance Before Regular Insulin Use, 2017

    Patient reaction to the Initial recommendation for insulin by their HCPValues by Location
    United States (n = 120)Canada (n = 74)
    Level of surprise when HCP first said it was time to take insulin, mean (SD)2.3 (1.0)2.2 (1.0)
     Not surprised at all, n (%)30 (25.0)20 (27.0)
     Slightly surprised, n (%)42 (35.0)28 (37.8)
     Moderately surprised, n (%)34 (28.3)14 (18.9)
     Very surprised, n (%)14 (11.7)12 (16.2)
    Level of being upset when HCP first said it was time to take insulin, mean (SD)2.8 (0.9)2.6 (1.0)
     Not upset at all, n (%)5 (4.2)8 (10.8)
     Slightly upset, n (%)46 (38.3)27 (36.5)
     Moderately upset, n (%)40 (33.3)22 (29.7)
     Very upset, n (%)29 (24.2)17 (23.0)
    Health care professional that helped most in decision to try insulin, n (%)
     Primary care physician72 (60.0)26 (35.1)
     Nurse practitioner11 (9.2)3 (4.1)
     Physician assistant5 (4.2)6 (8.1)
     Medical assistant1 (0.8)1 (1.4)
     Endocrinologist16 (13.3)23 (31.1)
     Nurse2 (1.7)2 (2.7)
     Dietician4 (3.3)1 (1.4)
     Diabetes educator4 (3.3)12 (16.2)
     Other5 (4.2)0 (0.0)
    Time passed between HCP first recommended taking insulin and actually taking it regularly, n (%)
     I started taking it right away62 (51.7)32 (43.2)
     Less than 1 week9 (7.5)7 (9.5)
     About 1 or 2 weeks10 (8.3)7 (9.5)
     About 1 month4 (3.3)8 (10.8)
     2–3 months14 (11.7)6 (8.1)
     4–6 months7 (5.8)5 (6.8)
     7–12 months9 (7.5)2 (2.7)
     More than 1 year5 (4.2)7 (9.5)
    Stopped insulin for period of 7 or more days since first starting insulin, n (%)12 (10.0)10 (13.5)
     During the first month after I first started taking insulin2 (16.7)3 (30.0)
     1–3 months after I first started taking insulin3 (25.0)3 (30.0)
     3–6 months after I first started taking insulin0 (0.0)2 (20.0)
     More than 6 months after I first started taking insulin7 (58.3)2 (20.0)
    • HCP, health care provider; SD, standard deviation.

    • View popup
    Table 4.

    United States Health care Provider Actions That Helped to Make the Decision to Give Insulin a Try—Surveyed Adult Type 2 Diabetes Mellitus Patients Experiencing Psychological Insulin Resistance Before Regular Insulin Use, United States, 2017

    DescriptionPatients with Occurrence (n = 120)Helpfulness among Patients with Occurrence
    n%Mean (1–4 Scale of Helpfulness*)% Helped Moderately or a Lot
    HCP walked patient through the whole process of exactly how to take insulin91(75.8)3.19(79.1)
    HCP encouraged the patient to contact his/her office immediately if the patient ran into any problems or had questions after starting insulin99(82.5)3.14(75.8)
    HCP showed patient an insulin pen85(70.8)3.13(74.1)
    HCP had patient try an injection himself/herself while patient was there in the office47(39.2)3.13(74.5)
    HCP told patient that starting insulin could help the patient to live a longer and healthier life86(71.7)3.12(79.1)
    HCP explained to the patient that the final decision to try insulin was patient's, not his/hers72(60.0)3.10(72.2)
    HCP reviewed patient’s blood sugar numbers with the patient, showing the patient that his/her diabetes was not under control and that action was needed106(88.3)3.08(73.6)
    HCP helped patient to see how simple it was to inject insulin80(66.7)3.01(76.3)
    HCP warned patient that he/she was likely to develop complications if the patient did not get started soon with insulin to control his/her diabetes85(70.8)3.00(67.1)
    HCP told patient that blood glucose numbers would improve after patient started insulin110(91.7)2.92(70.0)
    HCP took time to answer all the patient’s questions and address his/her concerns about insulin95(79.2)2.92(65.3)
    HCP told patient that by going on insulin, he/she might soon be able to discontinue other diabetes medications55(45.8)2.89(63.6)
    HCP reassured patient that taking insulin was not going to cause complications, like blindness, kidney disease, or a heart attack70(58.3)2.86(62.9)
    HCP helped patient to see that an insulin injection was not as painful as patient thought it might be68(56.7)2.84(61.8)
    HCP showed patient how small the actual needle was70(58.3)2.81(62.9)
    HCP told patient that starting insulin would help the patient to feel better100(83.3)2.81(61.0)
    HCP explained that insulin was a natural substance that the patient’s body needed93(77.5)2.81(64.5)
    HCP helped patient to understand that taking insulin did not have to be as much of a burden as the patient had feared91(75.8)2.79(64.8)
    HCP gave patient leaflets or other reading material about insulin74(61.7)2.77(60.8)
    HCP helped patient to understand how insulin works in patient’s body to lower blood sugars and improve patient’s health93(77.5)2.76(63.4)
    HCP said that the he/she could not continue to treat patient if the patient refused to start insulin21(17.5)2.76(61.9)
    HCP reassured patient that taking insulin did not mean that diabetes was now a more serious condition76(63.3)2.74(56.6)
    HCP explained that the patient might not have to take insulin forever69(57.5)2.72(58.0)
    HCP told patient about all of the positives and negatives of insulin and explained how the positives outweighed the negatives85(70.8)2.72(62.4)
    HCP took the time to ask the patient about the reasons why the patient did not want to take insulin74(61.7)2.72(59.5)
    HCP and patient talked about the real costs of insulin and insulin supplies and together figured out a way to make it more affordable51(42.5)2.67(54.9)
    HCP encouraged patient to try it for a while and see if it might help the patient feel better83(69.2)2.65(54.2)
    HCP reassured patient that the risk of having a serious problem with hypoglycemia while taking insulin was low74(61.7)2.65(51.4)
    HCP reassured the patient that he/she would help the patient avoid or minimize any weight gain because of taking insulin53(44.2)2.64(54.7)
    HCP gave an injection while patient was there in the office36(30.0)2.64(55.6)
    HCP helped patient to recognize that insulin was more natural than the pills the patient was taking60(50.0)2.63(53.3)
    HCP told patient that he/she just needed to trust that the HCP knew best and that getting started on insulin was the patient’s best option69(57.5)2.62(56.5)
    HCP helped patient get over his/her fears that others would treat the patient differently because he/she were taking insulin52(43.3)2.62(53.8)
    HCP helped patient to realize that insulin wasn’t going to cost patient as much money as the patient feared it would57(47.5)2.60(56.1)
    HCP helped patient meet other people who had already been taking insulin for a while17(14.2)2.53(52.9)
    Repeatedly over many visits, HCP kept trying to convince the patient to get started on insulin60(50.0)2.47(48.3)
    HCP referred patient to a class to help learn more about insulin48(40.0)2.46(39.6)
    HCP warned patient that he/she could not be responsible for what might happen if the patient did not start insulin soon40(33.3)2.45(42.5)
    • HCP, health care provider.

    • ↵* Level of helpfulness was scored on a scale of 1 (it did not help at all) to 4 (it helped a lot). Items that did not occur for patients were considered missing.

    • View popup
    Table 5.

    Canadian Health care Provider Actions That Helped to Make the Decision to Give Insulin a Try—Surveyed Adult Type 2 Diabetes Mellitus Patients Experiencing Psychological Insulin Resistance Before Regular Insulin Use, Canada 2017

    DescriptionPatients with Occurrence (n = 74)Helpfulness among Those with Occurrence
    n%Mean (1-4 Scale of Helpfulness*)% Helped Moderately or a Lot
    HCP walked patient through the whole process of exactly how to take insulin66(89.2)3.38(83.3)
    HCP encouraged the patient to contact his/her office immediately if the patient ran into any problems or had questions after starting insulin61(82.4)3.34(82.0)
    HCP helped patient to see how simple it was to inject insulin60(81.1)3.22(76.7)
    HCP showed patient how small the actual needle was51(68.9)3.22(82.4)
    HCP told patient that blood glucose numbers would improve after patient started insulin69(93.2)3.19(78.3)
    HCP took time to answer all the patient’s questions and address his/her concerns about insulin69(93.2)3.19(81.2)
    HCP helped patient to see that an insulin injection was not as painful as patient thought it might be54(73.0)3.19(79.6)
    HCP gave an injection while patient was there in the office34(45.9)3.15(73.5)
    HCP explained that the patient might not have to take insulin forever40(54.1)3.13(77.5)
    HCP told patient that by going on insulin, he/she might soon be able to discontinue other diabetes medications52(70.3)3.12(71.2)
    HCP told patient that starting insulin would help the patient to feel better65(87.8)3.11(75.4)
    HCP showed patient an insulin pen62(83.8)3.10(74.2)
    HCP told patient that starting insulin could help the patient to live a longer and healthier life64(86.5)3.09(75.0)
    HCP explained to the patient that the final decision to try insulin was patient’s, not his/hers57(77.0)3.09(77.2)
    HCP helped patient to understand that taking insulin did not have to be as much of a burden as the patient had feared68(91.9)3.07(75.0)
    HCP had patient try an injection himself/herself while patient was there in the office41(55.4)3.07(75.6)
    HCP reviewed patient's blood sugar numbers with the patient, showing the patient that his/her diabetes was not under control and that action was needed70(94.6)3.07(78.6)
    HCP explained that insulin was a natural substance that the patient's body needed67(90.5)3.04(73.1)
    HCP encouraged patient to try it for a while and see if it might help the patient feel better54(73.0)3.04(77.8)
    HCP warned patient that he/she was likely to develop complications if the patient did not get started soon with insulin to control his/her diabetes62(83.8)3.03(71.0)
    HCP reassured patient that the risk of having a serious problem with hypoglycemia while taking insulin was low62(83.8)2.97(72.6)
    HCP reassured patient that taking insulin was not going to cause complications, like blindness, kidney disease, or a heart attack51(68.9)2.96(70.6)
    HCP and patient talked about the real costs of insulin and insulin supplies and together figured out a way to make it more affordable41(55.4)2.95(70.7)
    HCP took the time to ask the patient about the reasons why the patient did not want to take insulin55(74.3)2.95(67.3)
    HCP helped patient to understand how insulin works in patient's body to lower blood sugars and improve patient's health62(83.8)2.94(74.2)
    HCP reassured patient that taking insulin did not mean that diabetes was now a more serious condition61(82.4)2.92(65.6)
    HCP helped patient get over his/her fears that others would treat the patient differently because he/she were taking insulin33(44.6)2.88(75.8)
    HCP told patient that he/she just needed to trust that the HCP knew best and that getting started on insulin was the patient's best option51(68.9)2.86(62.7)
    HCP warned patient that he/she could not be responsible for what might happen if the patient did not start insulin soon29(39.2)2.86(69.0)
    HCP gave patient leaflets or other reading material about insulin48(64.9)2.83(62.5)
    HCP helped patient to recognize that insulin was more natural than the pills the patient was taking50(67.6)2.82(64.0)
    HCP told patient about all of the positives and negatives of insulin, and explained how the positives outweighed the negatives60(81.1)2.82(65.0)
    HCP reassured the patient that he/she would help the patient avoid or minimize any weight gain because of taking insulin39(52.7)2.79(59.0)
    Repeatedly over many visits, HCP kept trying to convince the patient to get started on insulin37(50.0)2.76(59.5)
    HCP referred patient to a class to help learn more about insulin36(48.6)2.75(58.3)
    HCP helped patient to realize that insulin was not going to cost patient as much money as the patient feared it would41(55.4)2.71(58.5)
    HCP said that the he/she could not continue to treat patient if the patient refused to start insulin20(27.0)2.70(70.0)
    HCP helped patient meet other people who had already been taking insulin for a while20(27.0)2.30(50.0)
    • HCP, health care provider.

    • ↵* Level of helpfulness was scored on a scale of 1 (it did not help at all) to 4 (it helped a lot). Items that did not occur for patients were considered missing.

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family  Medicine: 33 (2)
The Journal of the American Board of Family Medicine
Vol. 33, Issue 2
March/April 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada
Tricia Tang, Danielle Hessler, William H. Polonsky, Lawrence Fisher, Beverly Reed, Tanya Irani, Urvi Desai, Magaly Perez-Nieves
The Journal of the American Board of Family Medicine Mar 2020, 33 (2) 198-210; DOI: 10.3122/jabfm.2020.02.190157

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada
Tricia Tang, Danielle Hessler, William H. Polonsky, Lawrence Fisher, Beverly Reed, Tanya Irani, Urvi Desai, Magaly Perez-Nieves
The Journal of the American Board of Family Medicine Mar 2020, 33 (2) 198-210; DOI: 10.3122/jabfm.2020.02.190157
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • 'Is Insulin Right for Me? Development of a theory-informed, web-based resource for reducing psychological barriers to insulin therapy in type 2 diabetes
  • Many Family Medicine Successful Interventions and Clinical Reviews for Common Illnesses
  • Google Scholar

More in this TOC Section

  • Integrating Adverse Childhood Experiences and Social Risks Screening in Adult Primary Care
  • A Pilot Comparison of Clinical Data Collection Methods Using Paper, Electronic Health Record Prompt, and a Smartphone Application
  • Associations Between Modifiable Preconception Care Indicators and Pregnancy Outcomes
Show more Original Research

Similar Articles

Keywords

  • Canada
  • Health Personnel
  • Insulin Resistance
  • Patient-Centered Care
  • Surveys and Questionnaires
  • Type 2 Diabetes
  • United States

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire